451 related articles for article (PubMed ID: 18410548)
21. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
[TBL] [Abstract][Full Text] [Related]
22. Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas.
Yu R; Bonert V; Saporta I; Raffel LJ; Melmed S
J Clin Endocrinol Metab; 2006 Dec; 91(12):5126-9. PubMed ID: 17018653
[TBL] [Abstract][Full Text] [Related]
23. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A
J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063
[TBL] [Abstract][Full Text] [Related]
24. AIP gene and familial isolated pituitary adenomas.
Ozfirat Z; Korbonits M
Mol Cell Endocrinol; 2010 Sep; 326(1-2):71-9. PubMed ID: 20457215
[TBL] [Abstract][Full Text] [Related]
25. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
[TBL] [Abstract][Full Text] [Related]
26. Aggressive pituitary adenomas occurring in young patients in a large Polynesian kindred with a germline R271W mutation in the AIP gene.
Jennings JE; Georgitsi M; Holdaway I; Daly AF; Tichomirowa M; Beckers A; Aaltonen LA; Karhu A; Cameron FJ
Eur J Endocrinol; 2009 Nov; 161(5):799-804. PubMed ID: 19684062
[TBL] [Abstract][Full Text] [Related]
27. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma.
Toledo RA; Lourenço DM; Liberman B; Cunha-Neto MB; Cavalcanti MG; Moyses CB; Toledo SP; Dahia PL
J Clin Endocrinol Metab; 2007 May; 92(5):1934-7. PubMed ID: 17341560
[TBL] [Abstract][Full Text] [Related]
28. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.
Morita K; Takano K; Yasufuku-Takano J; Yamada S; Teramoto A; Takei M; Osamura RY; Sano T; Fujita T
Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145
[TBL] [Abstract][Full Text] [Related]
29. Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.
Cai F; Zhang YD; Zhao X; Yang YK; Ma SH; Dai CX; Liu XH; Yao Y; Feng M; Wei JJ; Xing B; Jiao YH; Wei ZQ; Yin ZM; Zhang B; Gu F; Wang RZ
Eur J Endocrinol; 2013 Dec; 169(6):867-84. PubMed ID: 24050928
[TBL] [Abstract][Full Text] [Related]
30. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis.
Cuny T; Pertuit M; Sahnoun-Fathallah M; Daly A; Occhi G; Odou MF; Tabarin A; Nunes ML; Delemer B; Rohmer V; Desailloud R; Kerlan V; Chabre O; Sadoul JL; Cogne M; Caron P; Cortet-Rudelli C; Lienhardt A; Raingeard I; Guedj AM; Brue T; Beckers A; Weryha G; Enjalbert A; Barlier A
Eur J Endocrinol; 2013 Apr; 168(4):533-41. PubMed ID: 23321498
[TBL] [Abstract][Full Text] [Related]
31. Screening of
Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
[No Abstract] [Full Text] [Related]
32. Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers.
Georgitsi M; Karhu A; Winqvist R; Visakorpi T; Waltering K; Vahteristo P; Launonen V; Aaltonen LA
Br J Cancer; 2007 Jan; 96(2):352-6. PubMed ID: 17242703
[TBL] [Abstract][Full Text] [Related]
33. Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
Yarman S; Ogret YD; Oguz FS
Genet Test Mol Biomarkers; 2015 Jul; 19(7):394-8. PubMed ID: 25938168
[TBL] [Abstract][Full Text] [Related]
34. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Beckers A; Aaltonen LA; Daly AF; Karhu A
Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
[TBL] [Abstract][Full Text] [Related]
35. Genetic mutations in sporadic pituitary adenomas--what to screen for?
Lecoq AL; Kamenický P; Guiochon-Mantel A; Chanson P
Nat Rev Endocrinol; 2015 Jan; 11(1):43-54. PubMed ID: 25350067
[TBL] [Abstract][Full Text] [Related]
36. Risk category system to identify pituitary adenoma patients with
Caimari F; Hernández-Ramírez LC; Dang MN; Gabrovska P; Iacovazzo D; Stals K; Ellard S; Korbonits M;
J Med Genet; 2018 Apr; 55(4):254-260. PubMed ID: 29440248
[TBL] [Abstract][Full Text] [Related]
37. Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene.
Naves LA; Daly AF; Vanbellinghen JF; Casulari LA; Spilioti C; Magalhães AV; Azevedo MF; Giacomini LA; Nascimento PP; Nunes RO; Rosa JW; Jaffrain-Rea ML; Bours V; Beckers A
Eur J Endocrinol; 2007 Oct; 157(4):383-91. PubMed ID: 17893251
[TBL] [Abstract][Full Text] [Related]
38. Genome-wide scan identifies novel modifier loci of acromegalic phenotypes for isolated familial somatotropinoma.
Khoo SK; Pendek R; Nickolov R; Luccio-Camelo DC; Newton TL; Massie A; Petillo D; Menon J; Cameron D; Teh BT; Chan SP
Endocr Relat Cancer; 2009 Sep; 16(3):1057-63. PubMed ID: 19443539
[TBL] [Abstract][Full Text] [Related]
39. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
Hernández-Ramírez LC; Gabrovska P; Dénes J; Stals K; Trivellin G; Tilley D; Ferrau F; Evanson J; Ellard S; Grossman AB; Roncaroli F; Gadelha MR; Korbonits M;
J Clin Endocrinol Metab; 2015 Sep; 100(9):E1242-54. PubMed ID: 26186299
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update.
Karhu A; Aaltonen LA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R73-9. PubMed ID: 17613551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
